|Page (1) of 1 - 07/12/18||email article||print page|
(July 12, 2018)
Drug Infusion System Market Scenario
The drug infusion systems are medical devices that allow infusion of drugs like antibiotics, chemotherapy drugs, insulin, painkillers and others in a controlled manner. The increase in the prevalence of chronic diseases like cardiovascular disease, stroke, cancer, type 2 diabetes, obesity, and arthritis drives the market growth. According to the World Health Organization 2018, 70% of deaths occur due to non-communicable diseases like diabetes, heart disease, stroke, chronic lung disease and heart disease, stroke, cancer worldwide.
Also, the rising geriatric population, adoption of technologically advanced devices and rising healthcare spending provide favorable backgrounds for the market to grow. Also, due to their easy to use, portability, ergonomic design, and visual monitoring features favor the potential growth of the market.
The Global Drug Infusion System Market is segmented on the basis of product type, mode of administration, application, and end-user. The drug infusion system market, by product type, is sub-segmented into elastomeric infusion system, disposable infusion system, syringe infusion system, peristaltic pump, multi-channel pump, Patient-Controlled Analgesia (PCA) pump, insulin pump, and implantable infusion system. On the basis of application, the market is categorized into oncology/chemotherapy, diabetes, analgesia, nutrition, hematology, pediatrics, and others. The mode of administration is further sub-segmented into intravenous, subcutaneous, arterial, epidural, and others. On the basis of end-user, the market is segmented into hospitals, ambulatory surgical centers, diagnostic centers, and others.
On the basis of region, the global drug infusion system market is segmented into the Americas, Europe, Asia Pacific, and the Middle East and Africa.
Get Exclusive Sample Copy @ https://www.marketresearchfuture.com/sample_request/6207 .
The Americas is sub-segmented into North America and South America. The North American region is further segmented into the US and Canada. The European region is divided into two, namely, Western Europe and Eastern Europe. Western Europe is further classified into Germany, Italy, France, the UK, Spain, and the rest of Western Europe. The Asia Pacific region is sub-segmented into Japan, China, India, Australia, the Republic of Korea, and the rest of Asia Pacific. The Middle Eastern and African region is sub-segmented into the United Arab Emirates, Saudi Arabia, Oman, Kuwait, Qatar, and the rest of the Middle East and Africa.
Global Drug infusion system Market, by Key Players
- arcomed AG
- Braun Melsungen AG
- Becton Dickinson and Company
- Debiotech S.A.
- Fresenius SE & Co. KGaA
- Halyard Health, Inc
- ICU Medical Inc
- IRadimed Corporation
- Insulet Corporation
- Terumo Corporation
- Smiths Group plc
- Tandem Diabetes Care
- MOOG INC.
Regional Market Summary
The drug infusion system market is dominated by North America owing to the rising chronic diseases region. According to the Heart Disease and Stroke Statistics 2018, 836,546 deaths in the US were due to cardiovascular disease. Such a high incidence rate of cardiovascular diseases drives the market growth in this region
It is estimated that Europe stood second in the global Drug infusion system market. Increasing prevalence of chronic disease, rising health care expenditure and health care activities are driving the growth of this market in Europe. As per the Organization for Economic Co-operation and Development (OECD) in 2016, 550,000 working?age people died due to chronic disease in European Union countries. Such a high prevalence of chronic disease is expected to boost the market in this region.
Asia Pacific was projected to be the fastest growing region for the global Drug infusion system market.
Get Discount on Report @ https://www.marketresearchfuture.com/check-discount/6207 .
Drug infusion systems are frequently used for delivering insulin into patient’s body. Growing prevalence of diabetes influences the market in this region. According to the Asian Diabetes Prevention Initiative, 60% of the world’s diabetic population lives in Asia. This propels the growth of the market in this region.
The Middle East and Africa holds the least share in the global Drug infusion system market due to the presence of stringent government policies and poor economies. However, increasing investment by private market players in this region can boost the market growth.
Drug Infusion System Market Segmentation
Global Drug infusion system Market, by Product Type
- Elastomeric infusion system
- Disposable infusion system
- Syringe infusion system
- Peristaltic pump
- Multi-channel pump
- Patient-controlled analgesia (PCA) pump
- Insulin pump
- Implantable infusion system
Global Drug infusion system Market, by Application
Global Drug infusion system Market, by Region
- The Americas
- Asia Pacific
- The Middle East & Africa
Ask to Our Experts @ https://www.marketresearchfuture.com/enquiry/6207 .
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Company Name: Market Research FutureContact Person: Abhishek Sawant
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar
Related Keywords:Australia,Business,Health & Medicine,Science,U.S,
Related Sites: DMN Newswire , HTN - Health Technology Net
Related Newsletter: Tutorial Finder , Review Seeker , DMN Newswire Newsletter